Poljak M, Gale N, Kambic V, Ferluga D, Fischinger J
Institute of Microbiology, Medical Faculty of Ljubljana, Slovenia.
Anticancer Res. 1996 Jul-Aug;16(4A):1947-51.
This study investigated the immunohistochemical expression of p53 protein in various laryngeal lesions using Kambic's classification from simple hyperplasia to invasive squamous cell carcinoma (SCC), and analyzed the relationship between p53 protein overexpression and the severity of epithelial abnormalities. p53 overexpression was observed in 10/19 (53%), in 9/16 (56%), and in 9/13 (69%) cases of simple, abnormal, and atypical hyperplasia respectively, and also in 8/10 (80%) cases of SCC. The proportion of immunoreactive cells and staining intensity increased with the progression of the epithelial hyperplastic lesions. Our study confirms the association of p53 protein overexpression with laryngeal epithelial hyperplastic lesions which have the potential to transform into malignancy, but considering the follow-up of the patients, p53 expression cannot be considered a reliable prognostic factor for any group of laryngeal epithelial hyperplastic lesions regardless of the severity of the lesions.
本研究采用Kambic分类法,从单纯增生到浸润性鳞状细胞癌(SCC),调查了p53蛋白在各种喉病变中的免疫组化表达,并分析了p53蛋白过表达与上皮异常严重程度之间的关系。在单纯增生、异常增生和非典型增生病例中,分别有10/19(53%)、9/16(56%)和9/13(69%)观察到p53过表达,在SCC病例中也有8/10(80%)观察到p53过表达。免疫反应细胞的比例和染色强度随着上皮增生性病变的进展而增加。我们的研究证实了p53蛋白过表达与有恶变潜能的喉上皮增生性病变相关,但考虑到患者的随访情况,无论病变严重程度如何,p53表达都不能被视为任何一组喉上皮增生性病变的可靠预后因素。